Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Children's Oncology Group and Apeiron to collaborate on phase II study in neuroblastoma

Oct. 3, 2011

NanoCarrier and Kowa to enter worldwide agreement for NC-6300

Sep. 30, 2011

JDRF and iCo Therapeutics partner to support phase II iCo-007 study

Sep. 30, 2011

Vaxent and PREVENT to collaborate on group A Streptococcus vaccine

Sep. 30, 2011

NIH selects Afraxis for TRND program on PAK biology

Sep. 29, 2011

Riemser Arzneimittel receives German license for CINV combination therapy

Sep. 29, 2011

Photocure and Ipsen to commercialize Hexvix

Sep. 28, 2011

RXi acquires worldwide license for vaccine candidate targeting gynecological cancers

Sep. 23, 2011

BMS and Ambrx establish partnership for biologics

Sep. 23, 2011

Ariel Pharmaceuticals in-licenses lead product for acute migraine from BTG

Sep. 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...